AU615431B2 - Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids) - Google Patents

Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids) Download PDF

Info

Publication number
AU615431B2
AU615431B2 AU12592/88A AU1259288A AU615431B2 AU 615431 B2 AU615431 B2 AU 615431B2 AU 12592/88 A AU12592/88 A AU 12592/88A AU 1259288 A AU1259288 A AU 1259288A AU 615431 B2 AU615431 B2 AU 615431B2
Authority
AU
Australia
Prior art keywords
dideoxy
fluoro
aids
drug according
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU12592/88A
Other languages
English (en)
Other versions
AU1259288A (en
Inventor
Klaus Gaertner
Martin V. Janta-Lipinski
Peter Langen
Christine Lehmann
Eckart Matthes
Hans-Alfred Rosenthal
Dieter Scholz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27426554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU615431(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU1259288A publication Critical patent/AU1259288A/en
Application granted granted Critical
Publication of AU615431B2 publication Critical patent/AU615431B2/en
Assigned to WELLCOME FOUNDATION LIMITED, THE reassignment WELLCOME FOUNDATION LIMITED, THE Alteration of Name(s) of Applicant(s) under S113 Assignors: AKADEMIE DER WISSENSCHAFTEN DER DDR
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU12592/88A 1986-07-24 1988-03-03 Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids) Expired AU615431B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DD86292826A DD279407A1 (de) 1986-07-24 1986-07-24 Verfahren zur herstellung eines mittels gegen aids
DD30257387 1987-05-08
DD87303489A DD281346A5 (de) 1986-07-24 1987-06-03 Verfahren zur herstellung eines mittels gegen hiv-infektionen beim menschen
CA000571404A CA1333390C (fr) 1986-07-24 1988-07-07 Nucleosides fluores et methode de traitement des infections retrovirales avec ces nucleosides

Publications (2)

Publication Number Publication Date
AU1259288A AU1259288A (en) 1988-11-10
AU615431B2 true AU615431B2 (en) 1991-10-03

Family

ID=27426554

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12592/88A Expired AU615431B2 (en) 1986-07-24 1988-03-03 Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids)

Country Status (11)

Country Link
US (1) US4963662A (fr)
EP (1) EP0254268B2 (fr)
JP (1) JP2525418B2 (fr)
AU (1) AU615431B2 (fr)
CA (2) CA1333390C (fr)
DD (2) DD279407A1 (fr)
DE (1) DE3765045D1 (fr)
DK (1) DK378687A (fr)
ES (1) ES2036196T5 (fr)
GR (1) GR3001214T3 (fr)
NZ (1) NZ223836A (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) * 1909-10-07 2002-10-01 Medivir Ab Prodrugs
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US6448392B1 (en) 1985-03-06 2002-09-10 Chimerix, Inc. Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
US5446029A (en) * 1986-07-04 1995-08-29 Medivir Ab Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides
US5153180A (en) * 1986-07-24 1992-10-06 Eckart Matthes Fluorinated nucleosides and process for treating retrovirus infections therewith
EP0332626A1 (fr) * 1986-11-21 1989-09-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Composition pour traiter des infections virales chez des humains
US5459256A (en) * 1987-04-17 1995-10-17 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Lipophilic, aminohydrolase-activated prodrugs
US5495010A (en) * 1987-04-17 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services Acid stable purine dideoxynucleosides
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
JPS6468395A (en) * 1987-09-08 1989-03-14 Yamasa Shoyu Kk 3'-deoxyarbinofuranosylpyrimidine nucleoside derivative
EP0311107A3 (fr) * 1987-10-08 1990-04-18 Stichting REGA V.Z.W. Fluoro-3'-purine-didéoxy-2',3'-ribosides actifs contre HIV
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
US5506215A (en) * 1987-11-03 1996-04-09 Medivir Ab 1-(3'-fluoro-2',3'-dideoxy-β-D-ribofuranosyl)-5-substituted pyrimidine nucleosides
GB8726136D0 (en) * 1987-11-07 1987-12-09 Wellcome Found Therapeutic nucleosides
EP0316592A3 (fr) * 1987-11-13 1990-09-19 Stichting REGA V.Z.W. 3'-Fluoro-2',3'-didéoxyuridine, et ses application thérapeutique
US4997926A (en) * 1987-11-18 1991-03-05 Scripps Clinic And Research Foundation Deaminase-stable anti-retroviral 2-halo-2',3'-dideoxy
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
EP0355031A3 (fr) * 1988-08-17 1990-12-27 MATTHES, Eckart, Dr. Nucléosides pyrimidiniques substitués, leur procédé de préparation et médicaments les contenant
US5157114A (en) * 1988-08-19 1992-10-20 Burroughs Wellcome Co. 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
WO1990003978A1 (fr) * 1988-10-03 1990-04-19 Stichting Rega Vzw Composes de 5-halogeno-3'-fluoro-2',3'-didesoxyuridine et leur application therapeutique
WO1992006985A1 (fr) * 1990-10-23 1992-04-30 City Of Hope Inhibiteurs de methyltransferase d'adn fondes sur un mecanisme
DD293498A5 (de) * 1989-07-20 1991-09-05 Zi Fuer Molekularbiologie Der Adw,De Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von hepatits-infektionen bei mensch und tier
CA2073063A1 (fr) * 1989-11-06 1991-05-07 Jo Klaveness Derives nucleosidiques
GB9003543D0 (en) * 1990-02-16 1990-04-11 Wellcome Found Therapeutic nucleosides
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
US5180824A (en) * 1990-11-29 1993-01-19 Berlex Biosciences Inc. 6-azido-2-fluoropurine, useful in the synthesis of nucleosides
US5283331A (en) * 1990-12-20 1994-02-01 Nippon Kayaku Kabushiki Kaisha 2-halogeno-oxetanocin A and phosphoric ester thereof
US5663154A (en) * 1992-01-06 1997-09-02 Glaxo Wellcome Inc. 2',3'-dideoxy-3'-fluoro-purine ribonucleosides
WO1996011204A1 (fr) * 1994-10-07 1996-04-18 Max-Delbrück-Centrum für Molekulare Medizin NOUVEAUX β-L-NUCLEOSIDES ET LEUR UTILISATION
US5703058A (en) 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5728560A (en) * 1996-06-14 1998-03-17 Enzon, Inc. Method of treating CD4+ T cell lymphopenia in immuno-compromised patients
US6013790A (en) * 1996-09-25 2000-01-11 Board Of Regents University Of Nebraska-Lincoln Heavily fluorinated sugar analogs
DE19720151A1 (de) * 1997-05-02 1998-11-05 Max Delbrueck Centrum Chimäre Oligonucleotide und ihre Verwendung
US20020128301A1 (en) * 1998-02-13 2002-09-12 Medivir AB Non-nucleoside reverse transcriptase inhibitors
US7635690B2 (en) 1999-01-22 2009-12-22 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
US7115584B2 (en) * 1999-01-22 2006-10-03 Emory University HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
PL364995A1 (en) * 2000-02-18 2004-12-27 Shire Biochem Inc. Method for the treatment or prevention of flavivirus
BR0210594A (pt) * 2001-06-22 2005-11-01 Pharmasset Ltd (beta)-d ou (beta)-l-3-halonucleosìdeo
WO2003018030A1 (fr) * 2001-08-24 2003-03-06 Koronis Pharmaceuticals, Inc. Analogues de nucleoside mutagene pour le traitement d'une maladie virale
PL217132B1 (pl) 2010-06-30 2014-06-30 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Modyfikowane 2',3'-dideoksynukleozydy do leczenia zakażeń szczepami ludzkiego wirusa nabytego niedoboru odporności (HIV) wykazującymi oporność wielolekową, sposób ich wytwarzania oraz farmaceutycznie dopuszczalna forma leku
AR121620A1 (es) 2020-03-20 2022-06-22 Gilead Sciences Inc Profármacos de nucleósidos 4’-c-sustituidos-2-halo-2’-deoxiadenosina y métodos de preparación y uso de los mismos

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1189973A (en) * 1969-02-14 1970-04-29 Akad Wissenschaften Ddr Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE158902C (fr) *
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
DD158903A1 (de) * 1981-05-18 1983-02-09 Gotthard Kowollik Verfahren zur herstellung von 3'-fluor-2',3'-didesoxyadenosin
DD209197A1 (de) * 1981-07-21 1984-04-25 Akad Wissenschaften Ddr Verfahren zur herstellung von 3'-fluor-2',3'-didesoxyguanosin
JPH02240622A (ja) * 1989-03-14 1990-09-25 Canon Inc 防振光学系

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1189973A (en) * 1969-02-14 1970-04-29 Akad Wissenschaften Ddr Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides

Also Published As

Publication number Publication date
JP2525418B2 (ja) 1996-08-21
DK378687A (da) 1988-01-25
ES2036196T5 (es) 1995-08-16
EP0254268A2 (fr) 1988-01-27
JPS63107936A (ja) 1988-05-12
GR3001214T3 (en) 1992-07-30
ES2036196T3 (es) 1993-05-16
NZ223836A (en) 1990-12-21
EP0254268B1 (fr) 1990-09-19
DE3765045D1 (de) 1990-10-25
CA1336820C (fr) 1995-08-29
EP0254268A3 (en) 1988-07-13
DD279407A1 (de) 1990-06-06
DK378687D0 (da) 1987-07-21
CA1333390C (fr) 1994-12-06
AU1259288A (en) 1988-11-10
US4963662A (en) 1990-10-16
DD281346A5 (de) 1990-08-08
EP0254268B2 (fr) 1994-01-12

Similar Documents

Publication Publication Date Title
AU615431B2 (en) Fluorinated nucleosides: method for their preparation and use as drugs against the human acquired immunodeficiency syndrome (aids)
AU615705B2 (en) Adenosine deaminase-stable anti-retroviral nucleosides
US5118672A (en) 5'-diphosphohexose nucleoside pharmaceutical compositions
EP1589026B1 (fr) Dérivés de l'adénosine 2-halogénée et substituée en 4'-C
EP1058686B1 (fr) 2'-fluoronucleosides
US4833130A (en) Treatment of human viral infections
US4788181A (en) 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
EP0852499B1 (fr) Composes azides a usage therapeutique
JPH0780898B2 (ja) 抗ウイルスヌクレオシド
Mikhailopulo et al. Synthesis and antiviral and cytostatic properties of 3'-deoxy-3'-fluoro-and 2'-azido-3'-fluoro-2', 3'-dideoxy-D-ribofuranosides of natural heterocyclic bases
WO1988008001A1 (fr) Nucleosides et analogues de nucleosides, compositions et procedes pharmaceutiques permettant la preparation des composes
US5159067A (en) 5'-Diphosphohexose nucleoside pharmaceutical compositions
KR0138996B1 (ko) 치환된 아데닌 유도체 및 이를 함유하는 약제학적 조성물
US5084445A (en) 3'-azido-2',3'-dideoxy-5-methylcytidine
US5153180A (en) Fluorinated nucleosides and process for treating retrovirus infections therewith
EP0090405B1 (fr) Azole-dinucléotides et leurs méthodes de préparation
JP3202179B2 (ja) Ｈｉｖ−複製の強力な阻害剤としてのｓ−（＋）−アデノシルメチオニン及び３’−アジド−２’，３’ジデオキシ−ヌクレオシド複合体
US5077279A (en) 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
US5086044A (en) Treatment of human viral infections
US4990499A (en) Anti-herpes simplex virus activity of 5-alkoxymethyl-2'-deoxycytidimes and their 5-monophosphates
EP0516186A2 (fr) Nucléosides et analogues de nucléosides, compositions et procédés pharamaceutiques permettant la préparation des composés
HU192472B (en) Process for preparing /e/-5-/2-bromo-vinyl/-uracyl derivatives
EP0309560A1 (fr) Nucleosides et analogues de nucleosides, compositions et procedes pharmaceutiques permettant la preparation des composes.
CA2203672A1 (fr) Nucleosides de l-ribofuranosyle